CLINICAL_TRIALS
trial_result
· 2025-11-13
Clinical Trial Update: A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer [Phase 2]
Summary
Phase 2 study of Botensilimab in metastatic pancreatic ductal adenocarcinoma is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Agenus Inc. | Conditions: Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING